# Phase 19 Report — Channel-Specific Modalities And Tools

Date: 2026-05-09

## What Was Built

Phase 19 produced ADR-003 and the Reviewer Coverage Export Pack. ADR-003
compared voice transcription, OCR/image annotation, news/catalyst linking,
fund/equity data, reviewer UI/export improvements, and new channel lexicons
against the measured evidence-coverage bottleneck. It selected deterministic
reviewer/export improvements.

`SAS-MI-019` then added a local coverage exporter that maps source documents to
MarketIdea review status, evidence refs, deterministic outcome status, missing
fields, reviewer action, and reviewer ID.

## Why It Matters

The product now has a review surface for the actual blocker: turning 60 public
captures into reviewed evidence and deterministic outcome coverage before any
customer-facing report sample or sale. The phase avoids speculative provider or
modality expansion.

## Validation

- Before Phase 19: 138 passing tests after Phase 18.
- After `SAS-MI-018`: 138 passing tests.
- After `SAS-MI-019`: 141 passing tests.
- `ruff check src/ tests/` passes.
- `.venv/bin/pyright` passes.
- Phase 19 deep review archived at `docs/archive/PHASE19_REVIEW.md`.

## Review Results

- P0: 0
- P1: 0
- P2: 0
- Stop-Ship: No

## Open Risks

Coverage rows are not approved ledger truth and are not customer-facing report
claims. Human review is still required before using any row in a customer
sample.

## Health Verdict

OK. Phase 19 preserved Hybrid / Lean / T0, Tool-Use OFF, context-only RAG,
bounded/internal Agentic, and the public-source/non-advice boundaries.

## Next Phase

No next implementation task is defined in `docs/tasks.md`. The loop should stop
until the operator adds or approves a new task/phase.

## Notification Summary

Ph19 Channel Tools Scope DONE
Built: ADR-003, reviewer coverage export pack
Tests: 138->141 pass
Issues: P1:0 P2:0
Health: OK
Next: none defined
